射血分数保留心衰中冠脉微血管功能障碍的患病率与相关性:PROMIS-HFpEF研究
PROMIS-HFpEF是一项前瞻性多国多中心观察性研究,纳入202例严格符合指南标准的射血分数保留心衰(HFpEF)患者,排除已知未血运重建的大血管冠心病。采用腺苷负荷经胸多普勒超声测量冠脉血流储备(CFR),结果显示75%(95%CI 69-81%)存在冠脉微血管功能障碍(CMD,CFR<2.5),且CMD与全身内皮功能障碍、心衰严重程度及右室功能不全相关。
要点
- HFpEF患者中CMD(CFR<2.5)患病率高达75%(95%CI 69-81%)。
- CMD与当前或既往吸烟(70% vs 43%,P=0.0006)及房颤(58% vs 25%,P=0.004)相关。
- CFR越差与UACR、NTproBNP升高及RHI、TAPSE、右室游离壁应变降低独立相关。
核心结论
- PROMIS-HFpEF首次在前瞻性多国多中心研究中证实,无未血运重建大血管冠心病的HFpEF患者中CMD患病率高,且与全身内皮功能障碍及心衰严重程度相关。
- 微血管功能障碍可能是HFpEF有前景的治疗靶点。
研究设计与样本
- 前瞻性多国多中心观察性研究,纳入202例严格符合现行指南标准的HFpEF患者,排除已知未血运重建的大血管冠心病。
- 采用腺苷负荷经胸多普勒超声测量CFR,外周动脉张力测定测量RHI。
主要发现
- 202例HFpEF患者中151例[75%(95%CI 69-81%)]存在CMD(CFR<2.5)。
- CMD患者当前或既往吸烟比例更高(70% vs 43%,P=0.0006),房颤比例更高(58% vs 25%,P=0.004)。
- 校正年龄、性别、BMI、房颤、糖尿病、血运重建冠心病、吸烟、左室质量及研究中心后,CFR越差与UACR和NTproBNP越高、RHI和TAPSE及右室游离壁应变越低相关(所有关联P<0.05)。
关键数值与推荐
- CMD定义为CFR<2.5。
- HFpEF诊断依据现行指南严格标准。
- 排除已知未血运重建的大血管冠心病患者。
临床怎么用
- 对HFpEF患者应关注冠脉微血管功能障碍,尤其合并吸烟史或房颤者。
- CFR降低与全身内皮功能障碍(RHI、UACR)及心衰严重程度(NTproBNP、右室功能不全)相关,提示微血管功能障碍可作为潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF) with preserved ejection fraction (HFpEF) has been limited. We aimed to investigate the prevalence of coronary microvascular dysfunction (CMD) and its association with systemic endothelial dysfunction, HF severity, and myocardial dysfunction in a well defined, multi-centre HFpEF population. METHODS AND RESULTS: This prospective multinational multi-centre observational study enrolled patients fulfilling strict criteria for HFpEF according to current guidelines. Those with known unrevascularized macrovascular coronary artery disease (CAD) were excluded. Coronary flow reserve (CFR) was measured with adenosine stress transthoracic Doppler echocardiography. Systemic endothelial function [reactive hyperaemia index (RHI)] was measured by peripheral arterial tonometry. Among 202 patients with HFpEF, 151 [75% (95% confidence interval 69-81%)] had CMD (defined as CFR <2.5). Patients with CMD had a higher prevalence of current or prior smoking (70% vs. 43%; P = 0.0006) and atrial fibrillation (58% vs. 25%; P = 0.004) compared with those without CMD. Worse CFR was associated with higher urinary albumin-to-creatinine ratio (UACR) and NTproBNP, and lower RHI, tricuspid annular plane systolic excursion, and right ventricular (RV) free wall strain after adjustment for age, sex, body mass index, atrial fibrillation, diabetes, revascularized CAD, smoking, left ventricular mass, and study site (P < 0.05 for all associations). CONCLUSIONS: PROMIS-HFpEF is the first prospective multi-centre, multinational study to demonstrate a high prevalence of CMD in HFpEF in the absence of unrevascularized macrovascular CAD, and to show its association with systemic endothelial dysfunction (RHI, UACR) as well as markers of HF severity (NTproBNP and RV dysfunction). Microvascular dysfunction may be a promising therapeutic target in HFpEF.
引用
- Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018. PMID: 30165580. doi:10.1093/eurheartj/ehy531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。